Thứ ba, 28/09/2021 14:16 GMT+7

Các bài nghiên cứu mới về COVID-19 từ ngày 17/9 đến ngày 24/9/2021

Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 17/9 đến ngày 24/9/2021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

 

1. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019

Clinical Therapeutics, 8 January 2021, Volume 43, Issue 2, Pages 308-318

Yoel Benarroch, Lillian Juttukonda, Elizabeth Taglauer

https://www.sciencedirect.com/science/article/abs/pii/S0149291821000035

 

2. Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19

International Immunopharmacology, 9 September 2021, Volume 100, Article 108127

Mehmet Tahir HUYUT, Zübeyir HUYUT

https://www.sciencedirect.com/science/article/pii/S1567576921007633/pdfft?md5=c8ddc39dd7d6faf634935d6d36f0a23a&pid=1-s2.0-S1567576921007633-main.pdf

 

3. Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification

Journal of Ethnopharmacology, 22 January 2021, Volume 273, Article 113871

Shanshan Jia, Hua Luo, Wei Xiao

https://www.sciencedirect.com/science/article/pii/S0378874121000970/pdfft?md5=313faaf6ea31e14d40e8e355e98ea1dd&pid=1-s2.0-S0378874121000970-main.pdf

 

4. Recent progress of antiviral therapy for coronavirus disease 2019

European Journal of Pharmacology, 24 October 2020, Volume 890 (Cover date: 5 January 2021), Article 173646

Mengmeng Zhao, Jishou Zhang, Jun Wan

https://www.sciencedirect.com/science/article/abs/pii/S001429992030738X

 

5. A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)

International Immunopharmacology, 14 September 2021, Volume 100, Article 108137

Sajad Karampoor, Khashayar Hesamizadeh, Hossein Keyvani

https://www.sciencedirect.com/science/article/pii/S1567576921007736/pdfft?md5=2c6d493c4370c8b31c7dc194eabb5b5c&pid=1-s2.0-S1567576921007736-main.pdf

 

6. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2

Acta Pharmaceutica Sinica B11, March 2021, Volume 11, Issue 9, Pages 2850-2858

Haiyan Yan, Jing Sun, Jiandong Jiang

https://www.sciencedirect.com/science/article/pii/S2211383521000836/pdfft?md5=51e20b3bd234ad585180bbf0c8fcf7c5&pid=1-s2.0-S2211383521000836-main.pdf

 

7. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial

International Immunopharmacology, 12 June 2021, Volume 98, Article 107874

Emanuela Sozio, Amato De Monte, Carlo Tascini

https://www.sciencedirect.com/science/article/pii/S1567576921005105/pdfft?md5=b88937929c0a61e4b48e342681903141&pid=1-s2.0-S1567576921005105-main.pdf

 

8. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells

Vascular Pharmacology, 21 November 2020, Volume 137, Article 106823

Yuichiro J. Suzuki, Sofia I. Nikolaienko, Sergiy G. Gychka

https://www.sciencedirect.com/science/article/pii/S1537189120303281/pdfft?md5=51457c920072da885d6a466f6bc68f08&pid=1-s2.0-S1537189120303281-main.pdf

 

9. Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update

Food and Chemical Toxicology, 27 November 2020, Volume 147 (Cover date: January 2021), Article 111887

Shikha Thakur, Mayank, Gaurav Joshi

https://www.sciencedirect.com/science/article/abs/pii/S0278691520307778

 

10. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2

Journal of Ethnopharmacology, 24 June 2021, Volume 279, Article 114367

Qinhai Ma, Yuqi Xie, Zifeng Yang

https://www.sciencedirect.com/science/article/pii/S0378874121005961/pdfft?md5=6b26addb61db63719d042206c7c4c2f7&pid=1-s2.0-S0378874121005961-main.pdf

 

11. Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells

Antiviral Research, 9 August 2021, Volume 194, Article 105162

Olivier Escaffre, Alexander N. Freiberg

https://www.sciencedirect.com/science/article/pii/S0166354221001522/pdfft?md5=e54e88032d906b1052669916b0833ff7&pid=1-s2.0-S0166354221001522-main.pdf

 

12. COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?

Vascular Pharmacology, 22 April 2021, Volume 140, Article 106861

Vanessa Dela Justina, Fernanda R. Giachini, R. Clinton Webb

https://www.sciencedirect.com/science/article/pii/S1537189121000331/pdfft?md5=0e9ae1ec9921a7368c46ac9f346b1c49&pid=1-s2.0-S1537189121000331-main.pdf

 

13. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review

Food and Chemical Toxicology, 25 February 2021, Volume 150, Article 112087

Shukur Wasman Smail, Muhammad Saeed, Muhammad Safdar

https://www.sciencedirect.com/science/article/abs/pii/S0278691521001204

 

14. The use of negative oxygen ion clusters [O2−(H2O)n] and bicarbonate ions [HCO3−] as the supportive treatment of COVID-19 infections: A possibility

Medical Hypotheses, 5 August 2021, Volume 154, Article 110658

Ravindra V. Badhe, Sonali S. Nipate

https://www.sciencedirect.com/science/article/pii/S0306987721001778/pdfft?md5=fa5a488f3c10d19a20f1437a07e53528&pid=1-s2.0-S0306987721001778-main.pdf

 

15. Functional and druggability analysis of the SARS-CoV-2 proteome

European Journal of Pharmacology, 1 November 2020, Volume 890, Article 173705

Claudio N. Cavasotto, Maximiliano Sánchez Lamas, Julián Maggini

https://www.sciencedirect.com/science/article/abs/pii/S0014299920307974

 

16. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2

Antiviral Research, 12 July 2021, Volume 193, Article 105137

Franck Touret, Jean-Sélim Driouich,Antoine Nougairède

https://www.sciencedirect.com/science/article/pii/S0166354221001273/pdfft?md5=4f52b79d6ecf56d28b669e3f21d3b30b&pid=1-s2.0-S0166354221001273-main.pdf

 

17. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?

Medical Hypotheses, 6 June 2021, Volume 153, Article 110627

Amarnath Sen

https://www.sciencedirect.com/science/article/pii/S0306987721001468/pdfft?md5=fc4d13fabe196ee5263a4c84f34ffc2b&pid=1-s2.0-S0306987721001468-main.pdf

 

18. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19

Phytomedicine, 22 August 2020, Volume 85, Article 153310

Şevki Adem, Volkan Eyupoglu, Abdo A Elfiky

https://www.sciencedirect.com/science/article/abs/pii/S0944711320301422

 

19. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease

Chemico-Biological Interactions, 2 December 2020, Volume 335, Article 109348

Katrina L. Forrestall, Darcy E. Burley, Sultan Darvesh

https://www.sciencedirect.com/science/article/abs/pii/S0009279720312916

20. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo

Antiviral Research, 19 June 2021, Volume 192, Article 105115

Trinayan Kashyap, Jackelyn Murray, Yosef Landesman

https://www.sciencedirect.com/science/article/pii/S0166354221001054/pdfft?md5=b4ad4e45f4e1bdfbe2e8f3e841a39f58&pid=1-s2.0-S0166354221001054-main.pdf

 

21. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry

Pharmacological Research, 14 August 2021, Volume 172, Article 105820

Dingqi Zhang, Sami Hamdoun, Vincent Kam Wai Wong

https://www.sciencedirect.com/science/article/pii/S1043661821004047/pdfft?md5=3e16f55d2da954f09f31bb6a82a43987&pid=1-s2.0-S1043661821004047-main.pdf

 

22. The plausible mechanisms of tramadol for treatment of COVID-19

Medical Hypotheses, 22 December 2020, Volume 146, Article 110468

Nahla E. El-Ashmawy, Abdel-Halim A. Lashin, Mariam A. Abo-Saif

https://www.sciencedirect.com/science/article/abs/pii/S0306987720333594

 

23. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)

European Journal of Pharmacology, 27 November 2020, Volume 891 (Cover date: 15 January 2021), Article 173759

Chaima Mouffouk, Soumia Mouffouk, Hamada Haba

https://www.sciencedirect.com/science/article/abs/pii/S0014299920308517

 

24. Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

International Immunopharmacology, 26 December 2020, Volume 92 (Cover date: March 2021), Article 107329

Parvaneh Baghaei, Farzaneh Dastan, Payam Tabarsi

https://www.sciencedirect.com/science/article/pii/S1567576920337966

 

25. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro

Life Sciences, 10 December 2020, Volume 266 (Cover date: 1 February 2021), Article 118889

Jiayu Lu, Yajing Hou, Cheng Wang

https://www.sciencedirect.com/science/article/abs/pii/S0024320520316428

 

26. Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?

Medical Hypotheses, 4 January 2021, Volume 147, Article 110480

Niamh O'Kennedy, Asim K. Duttaroy

https://www.sciencedirect.com/science/article/pii/S0306987720333715/pdfft?md5=6f21a55f71fe7a45b4dcd61409aad252&pid=1-s2.0-S0306987720333715-main.pdf

 

27. Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel

European Journal of Pharmacology, 18 December 2020, Volume 893 (Cover date: 15 February 2021), Article 173813

Zheng Zequn, Wu Yujia, Lian Jiangfang

https://www.sciencedirect.com/science/article/pii/S0014299920309183/pdfft?md5=4e24ece784b6a2e37b2ccc1d6503e45b&pid=1-s2.0-S0014299920309183-main.pdf

 

28. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19

Medical Hypotheses, 7 January 2021, Volume 147, Article 110486

Antonio Vitiello, Raffaele La Porta, Francesco Ferrara

https://www.sciencedirect.com/science/article/abs/pii/S0306987721000049

 

29. Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2

Journal of Pharmaceutical Analysis, 7 September 2020, Volume 11, Issue 3 (Cover date: June 2021), Pages 272-277

Chao Liu, Xiaoxiao Zhu, Tai Yang

https://www.sciencedirect.com/science/article/pii/S209517792031042X/pdfft?md5=02507e6f5a5d2c4cfdfe8f0de9508eff&pid=1-s2.0-S209517792031042X-main.pdf

 

30. SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants

Medical Hypotheses, 6 November 2020, Volume 146 (Cover date: January 2021), Article 110368

Leo Pruimboom

https://www.sciencedirect.com/science/article/abs/pii/S030698772033259X

 

31. Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome

International Immunopharmacology, 2 December 2020, Volume 93 (Cover date: April 2021), Article 107239

Abolghasem Allahyari, Mohsen Seddigh-Shamsi, Neda Saeedian

https://www.sciencedirect.com/science/article/pii/S1567576920337061

 

32. B cell receptor (BCR) guided mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping

Medical Hypotheses, 6 July 2021, Volume 153, Article 110640

Kabeer Haneef, Abdul Ghaffar Memon, Mohd Sadeeq

https://www.sciencedirect.com/science/article/pii/S0306987721001596/pdfft?md5=4030a6d86d833e005742485da56ae4d6&pid=1-s2.0-S0306987721001596-main.pdf

 

33. Blood clots in COVID-19 patients: Simplifying the curious mystery

Medical Hypotheses, 6 November 2020, Volume 146 (Cover date: January 2021), Article 110371

Sourav Biswas, Vikram Thakur, Pradeep Kumar

https://www.sciencedirect.com/science/article/abs/pii/S030698772033262X

 

34. A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection

Antiviral Research, 8 July 2021, Volume 193, Article 105138

Esther S. Gan, Ayesa Syenina, Eng Eong Ooi

https://www.sciencedirect.com/science/article/pii/S0166354221001285/pdfft?md5=af950094a4e35824a0d5a255b5bb77e3&pid=1-s2.0-S0166354221001285-main.pdf

 

35. Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity

Food and Chemical Toxicology, 23 January 2021, Volume 149, Article 112007

Prem Rajak, Abhratanu Ganguly, Sumedha Roy

https://www.sciencedirect.com/science/article/abs/pii/S0278691521000417

 

36. Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside

Current Research in Pharmacology and Drug Discovery, 12 August 2021, Volume 2, Article 100045

Sijia TaoKeivan Zandi, Raymond F. Schinazi

https://www.sciencedirect.com/science/article/pii/S2590257121000328/pdfft?md5=af8a166bb80caa6d71cd1d59c0c7f35f&pid=1-s2.0-S2590257121000328-main.pdf

 

37. Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study

Medical Hypotheses, 9 August 2021, Volume 155, Article 110656

Ki Kwang Oh, Md. Adnan, Dong Ha Cho

https://www.sciencedirect.com/science/article/pii/S0306987721001754/pdfft?md5=56af13b577af5fdb97d5d0540ae386dc&pid=1-s2.0-S0306987721001754-main.pdf

 

38. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment

European Journal of Pharmacology, 17 May 2021, Volume 904, Article 174193

Abdolkarim Hosseini, Hadi Esmaeili Gouvarchin Ghaleh, Gholamreza

https://www.sciencedirect.com/science/article/abs/pii/S0014299921003460

 

39. Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2

European Journal of Pharmacology, 23 January 2021, Volume 896,  Article 173897

Shuai Ge, Xiangjun Wang, Huaizhen He

https://www.sciencedirect.com/science/article/abs/pii/S0014299921000509

 

40. Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead

European Journal of Pharmacology, 3 November 2020, Volume 890 (Cover date: 5 January 2021), Article 173717

Harmanjit Singh, Prerna Chauhan, Ashish Kumar Kakkar

https://www.sciencedirect.com/science/article/abs/pii/S0014299920308098

 

41. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?

Medical Hypotheses, 5 January 2021, Volume 147, Article 110479

Ciro Manzo, Jordi Serra-Mestres, Alberto Castagna

https://www.sciencedirect.com/science/article/abs/pii/S0306987720333703

 

42. In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain

European Journal of Pharmacology, 29 October 2020, Volume 890 (Cover date: 5 January 2021), Article 173701

Nouredine Behloul, Sarra Baha, Jihong Meng

https://www.sciencedirect.com/science/article/abs/pii/S0014299920307937

 

43. Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment

Biomedicine & Pharmacotherapy, 13 September 2021, Volume 143, Article 112159

Riffat Mehboob

https://www.sciencedirect.com/science/article/pii/S0753332221009434/pdfft?md5=b28d15ca1a7b83a8e9d17eefedd040ac&pid=1-s2.0-S0753332221009434-main.pdf

 

44. Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection

International Journal of Pharmaceutics, 18 August 2021, Volume 607, Article 121023

Shaymaa Elsayed Khater, Ahmed El-khouly, Dalia Mahmoud Ghorab

https://www.sciencedirect.com/science/article/pii/S0378517321008292/pdfft?md5=a9c64d2cde81c20b1c2d1b3841b2a249&pid=1-s2.0-S0378517321008292-main.pdf

 

45. Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage

Toxicology Reports, 8 July 2021, Volume 8, Pages 1394-1398

Athanasios ChalkiasIoannis Pantazopoulos, Eleni Arnaoutoglou

https://www.sciencedirect.com/science/article/pii/S2214750021001311/pdfft?md5=9f71752fb1ac76609fdb2571e1b35aa5&pid=1-s2.0-S2214750021001311-main.pdf

 

46. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients

International Immunopharmacology, 9 September 2021, Volume 100, Article 108125

Paula C. Teixeira, Gilson P. Dorneles, Pedro R. T. Romão

https://www.sciencedirect.com/science/article/pii/S156757692100761X/pdfft?md5=9e9624a0e628606ac70bdfc67504de9e&pid=1-s2.0-S156757692100761X-main.pdf

 

47. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors

European Journal of Medicinal Chemistry, 18 August 2021, Volume 225, Article 113789

Jiahua Cui, Jinping Jia

https://www.sciencedirect.com/science/article/pii/S0223523421006383/pdfft?md5=755a8a132586993c2125ae586a739e91&pid=1-s2.0-S0223523421006383-main.pdf

 

48. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target

Antiviral Research, 24 August 2021, Volume 194, Article 105167

Isabel García-Dorival, Miguel Ángel Cuesta-Geijo, Covadonga Alonso

https://www.sciencedirect.com/science/article/pii/S0166354221001571/pdfft?md5=0c4ffe6f78c183c8081f848db4d220c9&pid=1-s2.0-S0166354221001571-main.pdf

 

49. Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies

Biomedicine & Pharmacotherapy, 3 February 2021, Volume 137, Article 111356

Akalesh Kumar Verma, Vikas Kumar, Keun Woo Lee

https://www.sciencedirect.com/science/article/pii/S0753332221001414/pdfft?md5=c32bdd8691f42ed20ed1b51538aa0798&pid=1-s2.0-S0753332221001414-main.pdf

 

50. Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies

European Journal of Pharmacology, 29 October 2020, Volume 890 (Cover date: 5 January 2021), Article 173688

Pooja M, Gangavaram Jyothi Reddy, Bharathi Koganti

https://www.sciencedirect.com/science/article/abs/pii/S0014299920307809

 

51. Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19

European Journal of Pharmacology, 6 November 2020, Volume 890, Article 173720

Himanshu G. Toor, Devjani I. Banerjee, Siddhi A. Darji

https://www.sciencedirect.com/science/article/abs/pii/S0014299920308128

 

52. Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

Phytomedicine, 8 August 2021, Volume 91, Article 153704

Ting Xiao, Yuli Wei, Honggang Zhou

https://www.sciencedirect.com/science/article/pii/S0944711321002476/pdfft?md5=602f6fce37a45dd21628a83ae43868aa&pid=1-s2.0-S0944711321002476-main.pdf

 

53. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19

Medical Hypotheses, 12 November 2020, Volume 146 (Cover date: January 2021), Article 110394

Xiyuan Bai, Joseph Hippensteel, Edward D. Chan

https://www.sciencedirect.com/science/article/pii/S0306987720332850/pdfft?md5=5ffb9a5cf46383a849d3fecade729200&pid=1-s2.0-S0306987720332850-main.pdf

 

54. Crystal structure of SARS-CoV-2 papain-like protease

Acta Pharmaceutica Sinica B2,  September 2020, Volume 11, Issue 1 (Cover date: January 2021), Pages 237-245

Xiaopan Gao, Bo Qin, Sheng Cui

https://www.sciencedirect.com/science/article/pii/S2211383520306985/pdfft?md5=587371801e0d971b494a5c5fed1d4da4&pid=1-s2.0-S2211383520306985-main.pdf

 

55. Rapid detection of SARS-CoV-2 using a radiolabeled antibody

Nuclear Medicine and Biology, 25 May 2021, Volumes 98–99, Pages 69-75

Giacomo Pirovano, Alvaro A. Ordonez, Naga Vara Kishore Pillarsetty

https://www.sciencedirect.com/science/article/abs/pii/S0969805121004686

 

56. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

International Immunopharmacology, 29 June 2021, Volume 99, Article 107916

Ilad Alavi Darazam, Firouze Hatami, Navid Shafigh

https://www.sciencedirect.com/science/article/pii/S156757692100552X/pdfft?md5=8314e10debf50df6d6d2d331c0c4428e&pid=1-s2.0-S156757692100552X-main.pdf

 

57. IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients

International Immunopharmacology, 23 July 2021, Volume 99, Article 107998

Payam Tabarsi, Seyed Mohammad Reza Hashemian, Farzaneh Dastan

https://www.sciencedirect.com/science/article/pii/S1567576921006342/pdfft?md5=afc048b6449413638688772a846e3c3c&pid=1-s2.0-S1567576921006342-main.pdf

 

58. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase

Antiviral Research, 21 April 2021, Volume 190, Article 105078

Jianyuan Zhao, SaiSai Guo, Shan Cen

https://www.sciencedirect.com/science/article/pii/S0166354221000681/pdfft?md5=028d7dc7deae86277578ffefc8b21c42&pid=1-s2.0-S0166354221000681-main.pdf

 

59. Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

Biomedicine & Pharmacotherapy, 20 March 2021, Volume 138, Article 111526

Marcelo Augusto Duarte Silveira, David De Jong, Rogerio da Hora Passos

https://www.sciencedirect.com/science/article/pii/S0753332221003115/pdfft?md5=5e6d29579abd9c434478bf292c9c12fb&pid=1-s2.0-S0753332221003115-main.pdf

 

60. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CEuropean Journal of Pharmacology, 3 April 2021, Volume 901, Article 174082

Dhananjay Jade, Selvaraj Ayyamperumal, Moola Joghee NanjanLPRO proteases

https://www.sciencedirect.com/science/article/abs/pii/S0014299921002351

 

 

WILEY:

 

1. Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease

Arighna Sarkar, Kalyaneswar Mandal

Angewandte Chemie International Edition

First published: 21 September 2021                                        

https://onlinelibrary.wiley.com/doi/epdf/10.1002/anie.202107481

 

2. Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola

Cruz S. Sebastião, Celestina Gaston, Joana Paula Paixão, Euclides N.M. Sacomboio, Zoraima Neto, Jocelyne Neto de Vasconcelos, Joana Morais

Journal of Medical Virology

First published: 21 September 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27354

 

3. Metal complexes of Tridentate Schiff base: Synthesis, Characterization, Biological Activity and Molecular Docking Studies with COVID-19 Protein Receptor

Gehad Genidy mohamed, Mohamed Mohamed Omar, yasmin mamdoh hussien ahmed

Zeitschrift für anorganische und allgemeine Chemie

First published: 21 September 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/zaac.202100245

 

4. Preterm birth among women with and without severe acute respiratory syndrome coronavirus 2 infection

Matthew J. Blitz, Rachel P. Gerber, Moti Gulersen, Weiwei Shan, Andrew C. Rausch, Lakha Prasannan, Natalie Meirowitz, Burton Rochelson

Acta Obstetricia et Gynecologica Scandinavica

First published: 21 September 2021

https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/aogs.14269

 

5. Antibody Screening at Reduced pH Enables Preferential Selection of Potently Neutralizing Antibodies Targeting SARS-CoV-2

Bharat Madan, Eswar R. Reddem, Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Yaoxing Huang, Ahmed S. Fahad, Matheus Oliveira de Souza, Bailey B. Banach, Sheila N. López Acevedo, Xiaoli Pan, Rajani Nimrania, I-Ting Teng, Fabiana Bahna, Tongqing Zhou, Baoshan Zhang, Michael T. Yin, David D. Ho, Peter D. Kwong, Lawrence Shapiro, Brandon J. DeKosky

AIChE Journal

First published: 20 September 2021

https://aiche.onlinelibrary.wiley.com/doi/epdf/10.1002/aic.17440

 

6.  On the weak binding and spectroscopic signature of SARS-CoV-2 nsp14 interaction with RNA

Ayaz Hassan, Graziela C Sedenho, Phelipe A. M. Vitale, Mona N Oliveira, Frank Nelson Crespilho

ChemBioChem

First published: 20 September 2021

https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cbic.202100486

 

7.  COMPARISON OF PULSE-DOSE AND HIGH-DOSE CORTICOSTEROIDS WITH NO CORTICOSTEROID TREATMENT FOR COVID-19 PNEUMONIA IN THE INTENSIVE CARE UNIT

Hamid Yaqoob MD, Daniel Greenberg DO, Frank Hwang BS, Curtis Lee BA, David Vernik MBA, Ravi Manglani MD, Zhen Wang PhD, M. Hassan Murad MD, Dipak Chandy MD, Oleg Epelbaum MD

Journal of Medical Virology

First published: 20 September 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27351

 

8. Using Different Machine Learning Models to Classify Patients with Mild and Severe Cases of COVID-19 Based on Multivariate Blood Testing

Rui-kun Zhang, Qi Xiao, Sheng-lang Zhu, Hai-yan Lin, Ming Tang

Journal of Medical Virology

First published: 20 September 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27352

 

SPRINGER NATURE

 

1. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study

Qing-Lei Zeng, Zu-Jiang Yu, Fanpu Ji, Guang-Ming Li… in BMC Infectious Diseases (2021)

https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06572-z.pdf

 

2. Clinical Outcomes of Patients Hospitalized with Coronavirus Disease 2019 (COVID-19) in Boston

Areej El-Jawahri MD, Hacho B. Bohossian MD… in Journal of General Internal Medicine (2021)

https://link.springer.com/content/pdf/10.1007%2Fs11606-021-06622-x.pdf

 

3. A cluster randomized trial of interferon ß-1a for the reduction of transmission of SARS-Cov-2: protocol for the Containing Coronavirus Disease 19 trial (ConCorD-19)

Carolina Iturriaga, Nat Eiffler, Rad Aniba, Rym Ben-Othman… in BMC Infectious Diseases (2021)

https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06519-4.pdf

 

4. Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

Yuqing Cui, Yali Sun, Junyi Sun, Huoyan Liang… in Infectious Diseases and Therapy (2021)

https://link.springer.com/content/pdf/10.1007%2Fs40121-021-00518-3.pdf

 

5. The repurposed use of anesthesia machines to ventilate critically ill patients with coronavirus disease 2019 (COVID-19)

Maurizio Bottiroli, Angelo Calini, Riccardo Pinciroli, Ariel Mueller… in BMC Anesthesiology (2021)

https://link.springer.com/content/pdf/10.1186%2Fs12871-021-01376-9.pdf

 

6. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study

Tak Kyu Oh, In-Ae Song in BMC Pulmonary Medicine (2021)

https://link.springer.com/content/pdf/10.1186%2Fs12890-020-01387-1.pdf

 

7. Clinical value of blood markers to assess the severity of coronavirus disease 2019

Liu-Niu Xiao, Xiao Ran, Yan-Xia Zhong, Shu-Sheng Li in BMC Infectious Diseases (2021)

https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06623-5.pdf

 

Các công bố về COVID-19 trước thời gian trên:

 

Cập nhật các công bố về COVID-19 từ ngày 10/09 đến ngày 17/09/2021

https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-9-den-ngay-17-9-2021-4002.html

 

Cập nhật các công bố về COVID-19 từ ngày 27/08 đến ngày 03/09/2021

https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-8-den-ngay-3-9-2021-3953.html

 

Cập nhật các công bố về COVID-19 từ ngày 20/08 đến ngày 27/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-8-den-ngay-27-8-2021-3932.html

 

Cập nhật các công bố về COVID-19 từ ngày 13/08 đến ngày 20/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-8-den-ngay-20-8-2021-3904.html

 

Cập nhật các công bố về COVID-19 từ ngày 06/08 đến ngày 13/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-6-8-den-ngay-13-8-2021-3878.html

 

Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html

 

Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html

 

Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html

 

Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html

 

Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html

 

Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html

 

Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html

 

Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html

 

Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html

 

Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html

 

Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html

 

Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html

 

Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html

 

Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html

 

Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html

 

Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html

 

Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html

 

Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html

 

Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html

 

Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html

 

Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html

 

Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html

 

Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html

 

Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html

 

Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html

 

Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html

 

Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html

 

Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html

 

Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html

 

Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html

 

Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html

 

Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html

 

Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html

 

Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020

https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html

 

Cập nhật các công bố về COVID-19 đến ngày 07/6/2020

http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html

 

Cập nhật các công bố về COVID-19 đến ngày 01/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html

 

Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html

 

Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html

 

Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html

 

Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020

https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020

https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020

https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020

https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020

https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020

https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020

https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN

 

Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx

 

Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020 

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx

Nguồn: Cục Thông tin KH&CN quốc gia

Lượt xem: 1144

Tìm theo ngày :

Đánh giá

(Di chuột vào ngôi sao để chọn điểm)